Schematic overview of the cellular and molecular mechanisms involved in the cancer progression, including the proposed cellular and molecular mechanisms in cancer cells trajectory. AT1: alveolar type 1 cells; AT2: alveolar type 2 cells; AAH: atypical adenomatous hyperplasia; AIS: adenocarcinoma in situ; MIA: minimally invasive adenocarcinoma; IA: invasive adenocarcinoma; EMT: epithelial-mesenchymal transition

Home

Download

Statistics

Help

Contact

Center for Computational Systems Medicine
leaf

Gene summary

leaf

Malignant transformation analysis

leaf

Malignant transformation related pathway analysis

leaf

Cell-cell communication analysis

leaf

Single-cell gene regulatory network inference analysis

leaf

Somatic mutation of malignant transformation related genes

leaf

Related drugs of malignant transformation related genes

Gene: ARHGAP27P1-BPTFP1-KPNA2P3

Gene summary for ARHGAP27P1-BPTFP1-KPNA2P3

check button Gene summary.

Gene informationSpeciesHuman
Gene symbol

ARHGAP27P1-BPTFP1-KPNA2P3

Gene ID

109286553

Gene nameARHGAP27P1-BPTFP1-KPNA2P3 readthrough, transcribed pseudogene
Gene AliasARHGAP27P1-BPTFP1-KPNA2P3
Cytomap17q24.1
Gene Typepseudo
GO ID

NA

UniProtAcc

NA


Top

Malignant transformation analysis

check button Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells
check button Malignant transformation involving gene list.
Entrez IDSymbolReplicatesSpeciesOrganTissueAdj P-valueLog2FCMalignancy
109286553ARHGAP27P1-BPTFP1-KPNA2P3HTA11_3410_2000001011HumanColorectumAD1.36e-153.06e-010.0155
109286553ARHGAP27P1-BPTFP1-KPNA2P3HTA11_2487_2000001011HumanColorectumSER2.28e-266.54e-01-0.1808
109286553ARHGAP27P1-BPTFP1-KPNA2P3HTA11_2951_2000001011HumanColorectumAD2.49e-084.41e-010.0216
109286553ARHGAP27P1-BPTFP1-KPNA2P3HTA11_1938_2000001011HumanColorectumAD9.20e-327.63e-01-0.0811
109286553ARHGAP27P1-BPTFP1-KPNA2P3HTA11_78_2000001011HumanColorectumAD1.18e-195.21e-01-0.1088
109286553ARHGAP27P1-BPTFP1-KPNA2P3HTA11_347_2000001011HumanColorectumAD3.13e-335.78e-01-0.1954
109286553ARHGAP27P1-BPTFP1-KPNA2P3HTA11_411_2000001011HumanColorectumSER1.20e-076.90e-01-0.2602
109286553ARHGAP27P1-BPTFP1-KPNA2P3HTA11_2112_2000001011HumanColorectumSER5.26e-105.59e-01-0.2196
109286553ARHGAP27P1-BPTFP1-KPNA2P3HTA11_3361_2000001011HumanColorectumAD3.86e-113.50e-01-0.1207
109286553ARHGAP27P1-BPTFP1-KPNA2P3HTA11_83_2000001011HumanColorectumSER1.45e-175.64e-01-0.1526
109286553ARHGAP27P1-BPTFP1-KPNA2P3HTA11_696_2000001011HumanColorectumAD5.54e-315.14e-01-0.1464
109286553ARHGAP27P1-BPTFP1-KPNA2P3HTA11_866_2000001011HumanColorectumAD1.75e-183.66e-01-0.1001
109286553ARHGAP27P1-BPTFP1-KPNA2P3HTA11_1391_2000001011HumanColorectumAD1.09e-328.17e-01-0.059
109286553ARHGAP27P1-BPTFP1-KPNA2P3HTA11_2992_2000001011HumanColorectumSER1.94e-064.65e-01-0.1706
109286553ARHGAP27P1-BPTFP1-KPNA2P3HTA11_5212_2000001011HumanColorectumAD5.12e-052.80e-01-0.2061
109286553ARHGAP27P1-BPTFP1-KPNA2P3HTA11_546_2000001011HumanColorectumAD1.08e-124.15e-01-0.0842
109286553ARHGAP27P1-BPTFP1-KPNA2P3HTA11_7862_2000001011HumanColorectumAD2.47e-083.39e-01-0.0179
109286553ARHGAP27P1-BPTFP1-KPNA2P3HTA11_866_3004761011HumanColorectumAD2.70e-183.85e-010.096
109286553ARHGAP27P1-BPTFP1-KPNA2P3HTA11_4255_2000001011HumanColorectumSER2.17e-094.41e-010.0446
109286553ARHGAP27P1-BPTFP1-KPNA2P3HTA11_8622_2000001021HumanColorectumSER1.49e-062.87e-010.0528
Page: 1 2 

check button Transcriptomic changes along malignancy continuum.
TissueExpression DynamicsAbbreviation
Colorectum (GSE201348)The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.FAP: Familial adenomatous polyposis
CRC: Colorectal cancer
Colorectum (HTA11)The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.AD: Adenomas
SER: Sessile serrated lesions
MSI-H: Microsatellite-high colorectal cancer
MSS: Microsatellite stable colorectal cancer
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.

Top

Malignant transformation related pathway analysis

check buttonFind out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer
check button Figure of enriched GO biological processes.
TissueDisease StageEnriched GO biological Processes
ColorectumADGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumSERGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumMSSGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumMSI-HGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumFAPGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
Page: 1 2 3 4 5 6 7 8 9 

check button Enriched GO biological processes.
GO IDTissueDisease StageDescriptionGene RatioBg Ratiopvaluep.adjustCount
Page: 1 

check button Enriched KEGG pathways.
Pathway IDTissueDisease StageDescriptionGene RatioBg Ratiopvaluep.adjustqvalueCount
Page: 1 

Top

Cell-cell communication analysis

check buttonIdentification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states
LigandReceptorLRpairPathwayTissueDisease Stage
Page: 1 

Top

Single-cell gene regulatory network inference analysis

check buttonFind out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states
TFCell TypeTissueDisease StageTarget GeneRSSRegulon Activity
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
Page: 1 

Top

Somatic mutation of malignant transformation related genes

check buttonAnnotation of somatic variants for genes involved in malignant transformation
Hugo SymbolVariant ClassVariant ClassificationdbSNP RSHGVScHGVSpHGVSp ShortSWISSPROTBIOTYPESIFTPolyPhenTumor Sample BarcodeTissueHistologySexAgeStageTherapy TypesDrugsOutcome
Page: 1 

Top

Related drugs of malignant transformation related genes

check buttonIdentification of chemicals and drugs interact with genes involved in malignant transfromation
(DGIdb 4.0)
Entrez IDSymbolCategoryInteraction TypesDrug Claim NameDrug NamePMIDs
Page: 1